6-9 September 2018 | Kaohsiung, Taiwan

20th Asia Pacific League of Associations for Rheumatology Congress

6-9 September 2018 | Kaohsiung, Taiwan


Download PDF Program

Thursday 6 September 2018
ROOM 301 Grand Hall
1700 – 1800 Opening Ceremony
ROOM N2 Exhibition Hall
1800 – 1900 Welcome Reception and opening of Exhibition Hall


Friday 7 September 2018
ROOM 301 Grand Hall 304A 304B 305
SESSIONS Meet the experts SLE-from bench to bedside
Part 1: bench side
CHAIRS Hong-Wen Liu Chang Youh Tsai
0730 – 0800 Expression and impression: how to, rather how NOT to stage scientific presentation, Interactive, participative golden hour
Prakash Pispati
Understanding the genetic and epigenetic control of lupus by genome editing approach
Nan Shen
0800 – 0830 New insights into disease mechanisms and therapeutic approaches
Keith Elkon
CHAIRS Kazuhiko Yamamoto, Kuang-Hui Yu
0830 – 0915 Discovery of IL-6 and development of Anti-IL-6R antibody. Molecular mechanism of deregulated production of IL-6 in inflammatory diseases
Tadamitsu Kishimoto
0915 – 1000 Gout and hyperuricemia management update
Nicola Dalbeth
1030 – 1145 Industry symposium sponsored by Celltrion Healthcare Industry symposium sponsored by Chugai Pharmaceutical
SESSIONS Microbiota in rhematic diseases Biosimilars Oral paper presentation – clinical OA recent development
CHAIRS Zhanguo Li, Yen Ling-Jung Meng-Yu Weng, Yeong-Wook Song Kuen Horng Chen Chang Zhiyi, Hsiang-Cheng Chen
1145 – 1210 Fasting, a new way to improve human gut microbiome
Shaochuan Li
Critical review of publication of biosimilars
Eduardo Mysler
Efficacy and safety of baricitinib in MTX-IR Chinese patients with rheumatoid arthritis: 52 week results from a phase 3 study
Yue Yang
1145 – 1200
Development of LipocartigenTM, a SOX trio-transfected adipose stem cell therapeutics, to treat osteoarthritis
Gun-il Im
1145 – 1220
The Clinical Characters of Elder Onset Rheumatoid Arthritis
Jiali Chen
1200 – 1215
1210 – 1235 Tailored prebiotics for personalized therapy
Xin Wang
Naming and traceability
Mu Rong
Tofacitinib versus adalimumab versus abatacept in severe rheumatoid arthritis using high resolution ultrasound evaluation
Ying-chou Chen
1215 – 1230
Study on the safety of low-dose interleukin-2 in short-term treatment of rheumatoid arthritis
Fang Yuan Hu
1230 – 1245
Inflammatory phenotype of knee OA and its potential therapies
Qinghong Yu
1220 – 1255
1235 – 1300 Microbiota in health and inflammation
Shih-Chang Lin
Utility of biosimilars in rheumatology
Dae Hyun Yoo
Immunogenicity of novel interleukin inhibitor in chronic immune-mediated inflammatory diseases: a systematic review and meta-analysis
Dongze Wu
1245 – 1300
1300 – 1430 Industry symposium sponsored by Lilly Industry symposium sponsored by Pfizer – N2 Exhibition Hall
SESSIONS SLE- from bench to bedside
Part 2: bedside
Stem cell transplantation in rheumatic diseases SIG
Systemic manifestation of Scleroderma
CHAIRS Ho Youn Kim Chung-Tei Chou, Wu Lijun Joung Liang Lan Shue Fen Luo, Adeeba Al-Herz
1430 – 1455 Glucocorticoids and lupus – clinical and lab insights
Eric Morand
1430 – 1505
Application of hypoxic culture on mesenchymal stem cells: from bench to bedside
Shih-Chieh Hung
Biomarkers for predicting and monitoring to drug response in RA
Tsutomu Takeuchi
Pulmonary hypertension
Susanna Proudman
1455 – 1520 Development of cellular reprogramming and iPSC technology as personalized medicine-based platform: From bench to clinic bedside
Shih-Hwa Chiou
1505 – 1545
APLAR 2018 revised RA treatment recommendations
Chak-Sing Lau
Interstitial lung disease
Masataka Kuwana
Recent advances in the treatment of systemic lupus erythematosus
Chi-Chiu Mok
1505 – 1545
1520 – 1545 Rational DMARDS treatment and deep remission in rheumatoid arthritis
Zhanguo Li
Other aspects of scleroderma
Tsu-Yi Hsieh
SESSIONS New biomarkers in autoimmune diseases SIG
Oral paper presentation – clinical SIG
Ultrasound, Imaging & MRI
CHAIRS Naoto Tamura Jianlong Guan, Debashish Danda Tseng Jui Cheng, Nazrul Islam Chi-Chen Chang, Yi-Ming Chen
1615 – 1640 New biomarkers in polymyositis and dermatomyositis
Guochun Wang
Large vessel vasculitis – landmark papers from Asia Pacific region
Masayoshi Harigai
NMR-based Serum Metabolomics as surrogate for disease activity in inflammatory myositis
Latika Gupta
1615 – 1635
Ultrasound in inflammatory arthritis
Maria Antonietta D’Agostino
1615 – 1655
1640 – 1705 Urinary biomarkers predictive of disease activity in rheumatoid arthritis
Wan-Uk Kim
Metabolomic approach to study of vasculitis
Ramnath Misra
Identifying additional risk factors associated with thrombosis and pregnancy morbidity in antiphospholipid antibody positive patients
Chun Li
1635 – 1655
Correlation of TGF-β1 with clinical profile of patients with systemic sclerosis
Swati Parida
1655 – 1715
New imaging modalities for rheumatic disease
John Axford
1655 – 1730
1705 – 1730 Semaphorins and their involvement in the pathogenesis of autoimmune vasculitis
Masayuki Nishide
Teamwork in the management of ANCA-associated vasculitis
Chien-Sheng Wu
Low-dose IL-2 therapy in SLE
Zhang Ruijun
1715 – 1735
Neutrophil extracellular traps activate human lung fibroblasts by up-regulating TLR9 and down-regulating miR-7
Sigong Zhang
1735 – 1755
1930 Presidential Dinner by Invitation Only